China Feihe Limited (6186.HK)
Beijing, CN
China Feihe Limited operates as an investment holding entity primarily engaged in the production and sale of infant formula, serving consumers across Mainland China and the United States. Its comprehensive product portfolio extends to include raw and liquid milk, adult milk powders, various healthcare products, and specialized powders like soybean and goat milk. Furthermore, the company retails vitamins, minerals, herbal supplements, and other nutritional items. Products reach consumers through a multi-channel approach, utilizing third-party distributors, prominent e-commerce platforms such as Tmall, JD.com, and Suning.com, alongside its official website and mobile applications, including WeChat. By December 31, 2021, its extensive distribution network involved approximately 2,000 offline customers, managing 110,000 retail points of sale. China Feihe Limited was established in 1962 and is headquartered in Beijing, People's Republic of China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.66% | -1.61% | -12.07% | -19.47% | -26.09% | -24.63% | -49.75% | -34.33% | -85.93% | -58.87% | -58.87% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 5 | 0 |
| Hold | 7 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%-12.7% Q4'25: -8.5% (vs Q4'23)
-
EPS growth Packaged Foods: +14.6%-46.2% Q4'25: -47.4% (vs Q4'23)
-
FCF margin FCF growth · Packaged Foods: +15.9%+3.5% Q4'25: +13.9% (vs Q4'23)
-
EBIT margin Packaged Foods: +7.9%+15.6% ★ Q4'25: +12.9% (vs Q4'23)
-
ROIC Packaged Foods: +7.0%+16.5% ★ Q4'25: +28.9% (vs Q4'23)
-
Share dilution Packaged Foods: +0.0%-0.1% ★ Q4'25: -0.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×0.26× ★ Q4'25: 0.17× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 14 Rev. Ana. 14 EPS Ana. |
Dec 2027 16 Rev. Ana. 15 EPS Ana. |
Dec 2028 10 Rev. Ana. 9 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
13.72B
est: 15.32B (-10.5%)
|
18.59B
est: 22.20B (-16.3%)
|
22.78B
est: 28.44B (-19.9%)
|
21.31B
est: 24.33B (-12.4%)
|
19.53B
est: 18.50B (+5.6%)
|
20.75B
est: 20.73B (+0.1%)
|
18.11B
est: 18.80B (-3.6%)
|
19.02B
18.47B – 20.81B
+1.2% YoY
|
19.56B
18.28B – 24.74B
+2.8% YoY
|
19.95B
19.00B – 23.58B
+2.0% YoY
|
| EBITDA |
5.94B
est: 4.99B (+18.9%)
|
7.13B
est: 6.62B (+7.6%)
|
8.41B
est: 8.03B (+4.7%)
|
6.25B
est: 10.50B (-40.5%)
|
5.51B
est: 5.28B (+4.3%)
|
6.24B
est: 5.89B (+6.0%)
|
3.30B
est: 5.37B (-38.5%)
|
5.43B
5.28B – 5.94B
+1.2% YoY
|
5.58B
5.22B – 7.07B
+2.8% YoY
|
5.70B
5.43B – 6.73B
+2.0% YoY
|
| EBIT |
5.76B
est: 4.63B (+24.2%)
|
6.91B
est: 6.58B (+5.0%)
|
8.00B
est: 7.98B (+0.2%)
|
5.78B
est: 10.44B (-44.6%)
|
4.90B
est: 4.80B (+2.2%)
|
5.59B
est: 5.35B (+4.6%)
|
2.83B
est: 4.88B (-42.0%)
|
4.93B
4.79B – 5.40B
+1.2% YoY
|
5.07B
4.74B – 6.42B
+2.8% YoY
|
5.17B
4.93B – 6.12B
+2.0% YoY
|
| Net Income |
3.93B
est: 3.10B (+26.9%)
|
7.44B
est: 4.50B (+65.3%)
|
6.87B
est: 5.46B (+25.9%)
|
4.94B
est: 4.38B (+12.8%)
|
3.39B
est: 3.32B (+2.1%)
|
3.57B
est: 4.46B (-19.9%)
|
1.94B
est: 2.46B (-21.3%)
|
2.11B
2.04B – 3.44B
-14.3% YoY
|
2.42B
2.12B – 4.51B
+14.5% YoY
|
2.32B
2.26B – 3.17B
-4.3% YoY
|
| SGA |
4.76B
est: 5.93B (-19.7%)
|
6.42B
est: 5.46B (+17.5%)
|
7.94B
est: 6.63B (+19.8%)
|
8.08B
est: 8.66B (-6.7%)
|
8.47B
est: 7.69B (+10.2%)
|
8.86B
est: 8.57B (+3.5%)
|
8.84B
est: 7.81B (+13.3%)
|
7.90B
7.67B – 8.64B
+1.2% YoY
|
8.12B
7.59B – 10.28B
+2.8% YoY
|
8.29B
7.89B – 9.79B
+2.0% YoY
|
| EPS |
0.48
est: 0.34 (+40.2%)
|
0.83
est: 0.62 (+32.9%)
|
0.77
est: 0.79 (-3.0%)
|
0.55
est: 0.60 (-8.4%)
|
0.37
est: 0.37 (+0.9%)
|
0.39
est: 0.45 (-13.9%)
|
0.21
est: 0.26 (-19.2%)
|
0.28
0.23 – 0.38
+6.1% YoY
|
0.30
0.23 – 0.50
+7.2% YoY
|
0.30
0.25 – 0.35
+0.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Youbin Leng | Chairman & Chief Executive Officer | 21M | male |
| Fang-Liang Cai | President & Executive Director | 18M | male |
| Hua Liu | Vice Chairman & Chief Financial Officer | 6M | male |
| Fong-Yee Tu | Vice President, Company Secretary & Executive Director | 1M | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6186.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
